INTRODUCTION
Bacterial DNA gyrase and topoisomerase IV (topo IV) are type II topoisomerases, involved in controlling the topological state of bacterial DNA by ATP-dependent reaction mechanisms (Maxwell & Lawson, 2003; Ullsperger & Cozzarelli, 1996) . DNA gyrase, which is present in all known bacteria, has the unique ability to introduce negative supercoils into DNA, energetically driven by ATP hydrolysis. It is composed of the subunits GyrA and GyrB, which form a (GyrA) 2 (GyrB) 2 heterotetramer. Topo IV is composed of the subunits ParC and ParE, which form a similar tetrameric structure (ParC) 2 (ParE) 2 . The best-examined function of topo IV is the decatenation of daughter chromosomes following DNA replication; in addition, topo IV relaxes superhelical DNA. The subunits GyrA and ParC contain the catalytic centre for DNA cleavage and rejoining, while the GyrB and ParE subunits contain the catalytic centre for ATP hydrolysis.
Most bacteria possess both these type II topoisomerases. However, a different situation is encountered in members of the class of actinobacteria: the genome sequences of coryneform bacteria (Corynebacterium glutamicum; Corynebacterium efficiens) and of mycobacteria (Mycobacterium tuberculosis; Mycobacterium leprae) contain only genes for a single type II topoisomerase (i.e. gyrA and gyrB), but no homologues of parC and parE. Correspondingly, the gyrase of Mycobacterium smegmatis was demonstrated to be an efficient decatenase (Manjunatha et al., 2002) , and seems to carry out the functions of both gyrase and topo IV. So far, the existence of a separate topo IV has not been shown in the class of actinobacteria. Recently, however, the complete genome sequences of two additional actinobacteria have become available in the database, i.e. of Streptomyces coelicolor (SCO) and of Bifidobacterium longum (BL). These organisms contain genes for the DNA gyrase subunits A and B (gyrA and gyrB) and in addition two genes for another type II topoisomerase, currently annotated as 'putative DNA gyrase subunit A' and 'subunit B'. These genes will hereafter be called parX (SCO5822 and BL1434) and parY (SCO5836 and BL1429). In a sequence comparison of gyrase and topo IV genes from Gram-positive organisms, these parX and parY genes can neither be classified as gyrase nor as topo IV, but form independent groups on their own (Fig. 1) . No experimental data are available on the function of their encoded proteins.
Recently, we have identified type II topoisomerase genes as resistance genes within the biosynthetic gene clusters of novobiocin, clorobiocin and coumermycin A 1 (Schmutz et al., 2003) . These aminocoumarin antibiotics are potent inhibitors of the subunit B of gyrase (Maxwell, 1997) , and are produced by different Streptomyces strains. These organisms protect their own gyrase from the inhibitory effect of the aminocoumarins by de novo synthesis of an aminocoumarin-resistant gyrase B subunit during antibiotic formation (Schmutz et al., 2003; Thiara & Cundliffe, 1988 ) which showed high sequence similarity to parY of S. coelicolor (Fig. 1) . Upon expression in Streptomyces lividans, both gyrB R and parY R conferred resistance to aminocoumarin antibiotics.
In the present study, we have investigated the function of GyrB R and ParY R from the coumermycin A 1 producer Streptomyces rishiriensis DSM 40489. Both proteins were overexpressed and then purified by nickel affinity chromatography. After the additional purification of the GyrA and ParX subunits, we assembled the active heterotetrameric (GyrA) 2 (GyrB R ) 2 and (ParX) 2 (ParY R ) 2 topoisomerases in vitro and investigated their supercoiling, decatenation and relaxation activity. (ParX) 2 (ParY R ) 2 was found to have a pronounced decatenating activity and is believed to represent the first topo IV identified in actinobacteria.
METHODS
Bacterial strains, plasmids and culture conditions. For standard cloning procedures Escherichia coli XL1 Blue MRF9 (Stratagene) and standard protocols as described by Sambrook & Russell (2001) were used. S. lividans TK23 (Kieser et al., 2000) was used as host strain for the isolation of the Streptomyces vector pGM9 (Muth et al., 1989) and was grown in YMG medium (Kieser et al., 2000) at 28 uC for 2-3 days. For preparation of genomic DNA from S. coelicolor, YMG medium was used. Protoplast preparation and transformation of S. lividans T7 (Heinzelmann et al., 2001) for protein expression was carried out according to standard methods (Kieser et al., 2000) . E. coli transformants with pET-24a(+) or pGM9 fusion plasmids were selected with kanamycin (50 mg ml 21 ); transformants with pRSET B were selected with carbenicillin (50 mg ml 21 ). For selection of transformants of S. lividans T7, kanamycin (50 mg ml 21 ) was used. Transformants of S. lividans TK24 with pUWL201 expression constructs (Schmutz et al., 2003) were selected with thiostrepton (50 mg ml 21 ).
PCR amplification and cloning of topoisomerase genes. The primers used for PCR amplification of the topoisomerase genes are listed in Table 1 . gyrB R and parY R were amplified from the cosmid 4-2H described previously (Schmutz et al., 2003) . For amplification of the S. coelicolor genes gyrA and parX genomic DNA was used as template. Two different programmes for the amplification were used. For gyrB R , parY R and gyrA the conditions were 1 cycle at 95 uC (5 min), followed by 30 cycles at 95 uC (90 s), 60 uC (90 s) and 72 uC (5 min), and finally 1 cycle at 72 uC (10 min). parX was amplified by denaturation at 96 uC (5 min), followed by 30 cycles at 96 uC (2 min) and 72 uC (6 min), and finally 1 cycle at 72 uC (10 min). Each 100 ml volume of reaction mixture contained about 100 ng template cosmid DNA or 2-5 mg genomic DNA, 20 pmol of each primer, 0?2 mM dNTPs (each, final concentration), Pfu DNA polymerase reaction buffer (2 mM MgSO 4 , final concentration), 5 % (v/v) DMSO, and 3 units of Pfu DNA polymerase (Promega). The PCR products were digested with the restriction enzymes given in Table 1 and ligated into pRSET B (Invitrogen) (resulting in pRSET B-gyrB R , pRSET B-parY R and pRSET B-gyrA, respectively) or pET24a(+) (Novagen) (resulting in pET-24a-parX). To obtain plasmids replicating in Streptomyces, the pRSET B derivatives pRSET B-gyrB R , pRSET B-parY R and pRSET B-gyrA were digested with HindIII and fused with HindIII-digested pGM9. The construct pET-24a-parX was linearized with BglII and fused with BglII-digested pGM9.
Complementation of gyrB and parE temperature-sensitive mutants of E. coli. The E. coli strains N4177 (Menzel & Gellert, 1983) and W3110parE10 (Kato et al., 1990) contain either gyrB or parE with a mutation repressing the function of the resulting proteins at high temperature. Both strains were transformed either with pRSET B-gyrB R or with pRSET B-parY R . Transformed cells were grown on LB agar plates (Sambrook & Russell, 2001 ) containing carbenicillin (50 mg ml 21 ) and IPTG (0?5 mM). As a positive control pAG111 containing gyrB from E. coli (Hallett et al., 1990) transformed into strain N4177 was used. Cells transformed with pAG111 were grown on LB agar plates supplemented with carbenicillin (50 mg ml 21 ). One set of plates was incubated at 30 uC overnight, and the other was incubated at 42 uC overnight. Complementation was determined by the ability of the transformants to grow at 42 uC.
Protein expression and purification. S. lividans T7 strains harbouring the expression constructs were cultured in YEME medium (Kieser et al., 2000) supplemented with kanamycin (10 mg ml 21 ) for 2 days at 28 uC in baffled flasks. Each flask containing 200 ml YEME medium, supplemented with kanamycin (10 mg ml 21 ) and thiostrepton (25 mg ml 21 ), was inoculated with 4 ml of the preculture. After 24 h cultivation at 28 uC (170 r.p.m. in baffled flasks with steel springs) cells were harvested by centrifugation (5000 g, 4 uC, 10 min) and frozen overnight at 270 uC. For lysis the cells were thawed and resuspended in 1 ml lysis buffer (50 mM NaH 2 PO 4 , pH 8?0, 300 mM NaCl, 8 mg lysozyme ml 21 ) per g (wet wt) and incubated on ice for 30 min. Cells were broken by sonication (Branson Sonifier 250) for 10 min in 2 min intervals. The lysate was cleared by centrifugation (17 000 g, 4 uC, 30 min). The His-tagged proteins were purified by nickel affinity chromatography by using Ni-nitrilotriacetic acid resin (Qiagen). Some changes to the manufacturer's standard protocol were necessary in the washing procedure to obtain nearly homogeneous protein fractions. The imidazole concentration in the washing buffer was increased to 30-40 mM, and in the case of GyrB R , urea (2 M) was added to remove traces of GyrA subunit. After elution of the recombinant proteins with 250 mM imidazole, the buffer was exchanged by gel filtration on Sephadex G-25 NAP-10 columns (Amersham Biosciences). The storage buffer contained 50 mM KH 2 PO 4 , pH 7?5, 1 mM DTT, 0?2 mM EDTA and 50 % (v/v) glycerol. Refolding of denatured GyrB R protein was achieved by incubation overnight in storage buffer at 4 uC before storage at 220 uC.
The collected fractions were analysed by SDS-PAGE according to the method of Laemmli (1970) in 10 % gels.
DNA gyrase and topo IV activity assays. DNA gyrase and topo IV holoenzymes were reconstituted by mixing approximately equimolar amounts of recombinant GyrA and GyrB R and ParX and ParY R subunits in the reaction mixture, respectively. Enzyme activity was detected by incubation for 1 h at 30 uC in a total reaction volume of 20 ml containing 25 mM HEPES/KOH, pH 8?0, 10 mM magnesium acetate, 56 mM KCl, 2 mM DTT, 10 mM spermidine, 2 mM ATP and 50 mg BSA ml 21 . As substrates, 100 ng relaxed pBR322, 400 ng kinetoplast DNA (kDNA) (Topogen) and 100 ng supercoiled pBR322 were used for detection of supercoiling, decatenation and relaxation activity, respectively. The reaction was stopped by adding 4 ml loading buffer containing 200 mM EDTA, 30 % glycerol and 0?25 % bromphenol blue. Assays were analysed by electrophoresis on 0?8 % agarose gels in Tris/acetate/EDTA (TAE buffer) and staining with ethidium bromide. Electrophoresis with chloroquine was carried out on a 1?6 % agarose gel with 8?1 mg chloroquine phosphate ml 21 (corresponding to 5 mg ml 21 chloroquine base) in TAE buffer. Electrophoresis was performed in TAE buffer containing the same chloroquine concentration and run overnight. The gel was then washed three times for 30 min in 10 mM MgSO 4 in TAE buffer, and in distilled water before staining with ethidium bromide.
For testing the aminocoumarin resistance of supercoiling activity, 10-500 mg ml 21 novobiocin (dissolved in buffer) was added to the incubation mixture. For testing the aminocoumarin resistance of decatenation activity, 2?5-100 mg ml 21 novobiocin (dissolved in buffer) was added. IC 50 was defined as the novobiocin concentration causing 50 % inhibition of the supercoiling or of the decatenation reaction.
Supercoiled plasmid DNA of pBR322 was obtained by isolation from E. coli XL1 Blue MRF9 with ion-exchange columns (Nucleobond AX kits, Macherey-Nagel). Relaxation of supercoiled pBR322 was carried out with topoisomerase I (Amersham Biosciences) according to the manufacturer's instructions.
RESULTS
Complementation experiments with temperature-sensitive gyrB and parE mutants of E. coli
In E. coli, temperature-sensitive mutations affecting either gyrB or parE have been isolated (Kato et al., 1990; Menzel & Gellert, 1983) . These mutants grow normally at 30 uC. If the temperature is raised to 42 uC, the function of the respective enzyme is repressed and the mutant stops growing, since both gyrase and topo IV are essential for growth. Complementation of such mutants can be achieved with genes encoding a gyrase B subunit or a topo IV ParE subunit, respectively, restoring growth at elevated temperature (Kato et al., 1992) .
In order to test the function of gyrB R and parY R from the coumermycin cluster, both genes were cloned into the pRSET B vector. Each was transformed into the temperaturesensitive gyrB or parE mutants of E. coli. However, neither of the genes allowed growth at raised temperature. In contrast, transformation with a vector containing the respective 
GyrA and ParX
Attempts to purify GyrB R and ParY R as hexahistidine fusion proteins after expression in E. coli using the pRSET B vector were unsuccessful, since the proteins were contained in insoluble form in inclusion bodies. Therefore, Streptomyces strains were chosen for further expression experiments. GyrB R and ParY R were first expressed in S. lividans TK24, using the Streptomyces expression vector pUWL201. Affinity chromatography on novobiocinSepharose (Staudenbauer & Orr, 1981; Thiara & Cundliffe, 1988) allowed the purification of the genuine aminocoumarin-sensitive GyrB protein from S. lividans, which could be reconstituted with GyrA from the same organism to yield active gyrase. However, the aminocoumarinresistant GyrB R and ParY R proteins did not bind to the affinity column and apparently eluted with the bulk of the proteins. Therefore, a different purification strategy had to be devised.
The pRSET B vectors constructed for expression in E. coli (see above) encoded hexahistidine fusion proteins of GyrB R and ParY R , suitable for purification by nickel affinity chromatography. In order to allow replication of these vectors and expression of GyrB R and ParY R in S. lividans, they were fused with the vector pGM9, which contains an origin of replication for Streptomyces (Muth et al., 1989) . The resulting vectors were introduced into S. lividans T7, which contains a thiostrepton-inducible gene for T7 RNA polymerase (Heinzelmann et al., 2001) . After induction, crude protein extracts were prepared and subjected to nickel affinity chromatography. This resulted in nearly homogeneous ParY R protein, detected in the SDS gel at the expected molecular mass of 81 kDa (Fig. 2, lane 3) . The GyrB R protein, however, appeared to form a very stable complex with GyrA of S. lividans T7 and therefore coeluted with GyrA (data not shown). Complete removal of GyrA was finally achieved by elution of the nickel affinity column with 2 M urea. GyrB R remained on the column and could subsequently be eluted with 250 mM imidazole, although in denatured form. Removal of imidazole and storage overnight at 4 u C resulted in the renaturation of GyrB R . The protein still contained two minor impurity bands (Fig. 2, lane 1) , which however did not interfere with the assay. The additional required subunits GyrA and ParX were cloned from the completely sequenced organism S. coelicolor, expressed in S. lividans T7 and purified by essentially the same procedure (see Methods), resulting in nearly homogeneous proteins (Fig. 2, lanes 2 and 4) .
Investigation of supercoiling, decatenation and relaxation activities
Gyrase introduces negative supercoils into DNA, energetically driven by hydrolysis of ATP. Topo IV catalyses the catenation/decatenation of DNA and relaxes supercoiled DNA, with both reactions being dependent on the presence of ATP (Maxwell & Lawson, 2003) .
Using relaxed and supercoiled pBR322 as well as catenated kinetoplast DNA, we investigated the supercoiling, relaxation and decatenation activity of the purified topoisomerase subunits in different combinations. As shown in Fig. 3(a) (lane 2) , the complex of GyrA and GyrB R efficiently catalysed the supercoiling reaction. However, no ATPdependent relaxation or decatenation was catalysed by this protein (lanes 2 in Fig. 3b, c) , consistent with the expectation that the (GyrA) 2 (GyrB R ) 2 complex functions as a gyrase.
On the other hand, the complex of ParX and ParY R showed clear relaxation and decatenation activity (lanes 3 in Fig. 3b, c) , proving that these proteins function as subunits of topo IV. The subunits of gyrase and topo IV could not be interchanged: combinations of ParX with GyrB R , or of GyrA with ParY R , were not enzymically active in any of the three test systems (Fig. 3, lanes 4 and 5) . All three observed reactions were dependent on the presence of ATP (Fig. 3, lanes 6) .
From the experiment shown in Fig. 3(a) (lane 3) , it appeared that the complex of ParX and ParY R showed a low supercoiling activity. However, when the experiment was repeated and gel electrophoresis was performed in the presence of 5 mg chloroquine ml 21 , it was obvious that the complex of ParX and ParY R had no supercoiling activity (Fig. 4) .
Aminocoumarin resistance of GyrB R and ParY R In our previous study (Schmutz et al., 2003) , we had shown in vivo that gyrB R and parY R confer resistance to novobiocin and coumermycin A 1 , i.e. that they are likely to encode aminocoumarin-resistant topoisomerase subunits. This was now investigated in vitro. The gyrase of S. lividans is highly sensitive to novobiocin, with an IC 50 value of approximately 0?5 mg ml 21 (Thiara & Cundliffe, 1988) , very similar to the IC 50 of E. coli gyrase, which was determined as approximately 0?6 mg ml 21 (Peng & Marians, 1993) . In contrast, we observed an IC 50 of 50 mg ml 21 for the complex of GyrA and GyrB R . Likewise, bacterial topo IV is . DNA gyrase and topo IV activity assays: (a) supercoiling assay; (b) relaxation assay; (c) decatenation assay. Assay conditions were as described in Methods. In all assays equal amounts of the purified proteins were used. Assays were analysed by loading on a 0?8 % agarose gel and electrophoresis in TAE buffer. Gels were stained with ethidium bromide.
Relaxed pBR322
Supercoiled pBR322 . Supercoiling and relaxation assay with DNA gyrase and topo IV. Each assay was divided and equal amounts were loaded on a 1 % agarose gel in TAE buffer (a) and a 1?6 % agarose gel with 5 mg chloroquine ml "1 in TAE buffer (b). Both gels were stained with ethidium bromide.
sensitive to aminocoumarins (Hardy & Cozzarelli, 2003; Peng & Marians, 1993) , with an IC 50 of 1?5 mg ml 21 reported for the (ParC) 2 (ParE) 2 complex of E. coli (Peng & Marians, 1993) . In contrast, the (ParX) 2 (ParY R ) 2 complex investigated in this study showed an IC 50 of 20 mg ml 21 in the decatenation assay.
DISCUSSION
In this study, we present for the first time evidence for the existence of a topo IV in actinobacteria. Mycobacteria and corynebacteria possess only a single type II topoisomerase, which apparently has both supercoiling and decatenating activity (Manjunatha et al., 2002) . We have shown that streptomycetes (which also belong to the actinobacteria) contain both a gyrase, which consists of GyrA and GyrB subunits and catalyses the supercoiling of DNA, and a topo IV, consisting of the ParX and ParY subunits and catalysing the ATP-dependent decatenation and relaxation of DNA.
The topo IV which was investigated in the present study in vitro and in our previous study in vivo (Schmutz et al., 2003) contained the ParX subunit of S. coelicolor and the ParY R subunit from the coumermycin biosynthetic gene cluster of S. rishiriensis. This demonstrates the compatibility of the topo IV subunits from different Streptomyces strains. In the same way, the compatibility of the gyrase subunits A and B from different strains was shown. In contrast, the failure to complement E. coli gyrB and parE mutants with gyrB R and parY R from Streptomyces indicated that the Streptomyces proteins may not form functional topoisomerases with their counterparts from E. coli, as observed previously (Simon et al., 1995) . However, our results do not rule out the possibility of a partial complementation, which may be observable under less stringent conditions. Genome sequencing of S. coelicolor and Bifidobacterium longum has demonstrated in each organism the presence of a gyrA and a gyrB gene as well as of a parX and a parY gene (Figs 1 and 5) . For both organisms, the genes corresponding to parX and parY are at present annotated as 'putative DNA gyrase subunits' in the database. Our study has now shown that these genes encode a topo IV rather than a gyrase.
In the genomes of most Gram-positive bacteria, parE and parC are immediately adjacent genes, probably transcribed as a single operon, as observed for gyrB and gyrA (Fig. 5) . In contrast, in S. coelicolor and in B. longum, parX and parY have opposite orientations and are separated by a stretch of 13 and 8 kb, respectively. Therefore parX and parY are regulated by different promoters. A similar situation is encountered in Streptomyces avermitilis, which has recently been sequenced (Omura et al., 2001) .
gyrB
R and parY R from the coumermycin biosynthetic gene cluster in S. rishiriensis protect this organism from the toxic effect of its own antibiotic. A gyrB R gene is also found in the biosynthetic gene cluster of novobiocin (Steffensky et al., 2000) , and the function of this gene and the regulation of its expression has been investigated by Thiara & Cundliffe (1988 . The fact that the coumermycin cluster contains not only a gyrB R gene but also a parY R gene (which is absent in the novobiocin cluster) is consistent with the very high affinity of coumermycin A 1 both for gyrase and for topo IV (Peng & Marians, 1993) , creating the need to efficiently protect both enzymes in the coumermycin producer. This finding gives additional support to the hypothesis that topo IV is a biological target of coumermycin A 1 , as well as of clorobiocin, since the biosynthetic gene cluster of the latter antibiotic contains both gyrB R and parY R resistance genes (Schmutz et al., 2003) .
Present evidence suggests that for gyrase inhibitors of the fluorquinolone type, gyrase is the primary target in Gramnegative organisms, but often topo IV is the primary target in Gram-positive organisms (Blanche et al., 1996) . In contrast, for gyrase inhibitors of the aminocoumarin type, gyrase appears to be the primary target both in Gramnegative and in Gram-positive organisms, with topo IV representing a secondary target (Blanche et al., 1996; Hardy & Cozzarelli, 2003) . The high affinity of coumermycin and clorobiocin to both their primary and secondary targets may explain the need of the antibiotic producers to create a resistance mechanism protecting both targets, which is realized by the expression of the GyrB R and ParY R proteins.
